Jean-francois F. Cailhier

Montreal, QC, CA 
Montreal, QC, CA 

Overview

Jean-francois Cailhier practices practicing medicine in Montreal, Canada.

Their clinical expertise encompasses Diabetic Nephropathy, Wilson Disease, Melanoma, and Interstitial Nephritis.

They are actively involved in clinical research, co-authoring 44 peer reviewed articles and participating in 3 clinical trials.

Locations

Montreal, QC H2X0C1, Canada
Other Locations
H2X0A9, Canada
Edmonton, AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Evaluation of the Impact of Online Hemodiafiltration vs Conventional Hemodialysis in Acute Kidney Injury on Inflammatory and Clinical Outcomes
Evaluation of the Impact of Online Hemodiafiltration vs Conventional Hemodialysis in Acute Kidney Injury on Inflammatory and Clinical Outcomes
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Device
Study Phase: Not Applicable
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Diagnostic test
View 2 Less Clinical Trials

44 Total Publications

A mixed inflammatory peripheral signature defines clinical outcomes in a phase II trial combining pembrolizumab with paclitaxel and carboplatin in melanoma.
A mixed inflammatory peripheral signature defines clinical outcomes in a phase II trial combining pembrolizumab with paclitaxel and carboplatin in melanoma.
Journal: Oncoimmunology
Published: February 24, 2026

Frequently Asked Questions about Jean-francois F. Cailhier

Is Jean-francois F. Cailhier a top-rated expert for Diabetic Nephropathy?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-francois F. Cailhier is classified as an Experienced expert for Diabetic Nephropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-francois F. Cailhier participate in research or clinical trials?

Yes. Jean-francois F. Cailhier has published 44 articles and abstracts on conditions like Diabetic Nephropathy. You can view a list of Jean-francois F. Cailhier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cailhier's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile